24056-34-6 Usage
General Description
Cyclohexanecarbonitrile, 4-hydroxy- is a chemical compound with the molecular formula C7H11NO. It is a yellow, crystalline solid that is commonly used in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. It is also utilized as an intermediate in the production of dyes, perfumes, and flavorings. Cyclohexanecarbonitrile, 4-hydroxy- is a key building block for the manufacture of various important organic compounds, and it plays a crucial role in the fields of medicinal chemistry and chemical research. Its unique chemical properties and versatile applications make it an important and valuable compound in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 24056-34-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,0,5 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 24056-34:
(7*2)+(6*4)+(5*0)+(4*5)+(3*6)+(2*3)+(1*4)=86
86 % 10 = 6
So 24056-34-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H11NO/c8-5-6-1-3-7(9)4-2-6/h6-7,9H,1-4H2
24056-34-6Relevant articles and documents
BENZAMIDES OF PYRAZOLYL-AMINO-PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
-
Paragraph 00570, (2020/07/07)
Provided is a novel class of orally and/or topically available, selective and potent JAK inhibitors as safe and effective therapeutics against various diseases and disorders. More particularly, provided are pharmaceutical composition of these compounds and methods of their preparation and use thereof.
TRIAZOLE ACC INHIBITORS AND USES THEREOF
-
Paragraph 0887-0889, (2017/07/06)
The present invention provides triazole compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.
SUBSTITUTED ISOQUINOLINES AND ISOQUINOLINONES AS RHO KINASE INHIBITORS
-
Page/Page column 156, (2010/01/30)
The invention relates to substituted isoquinoline and isoquinolinones of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
